不同α-突触核蛋白株在突触核蛋白病中的播种变异性
本研究分析痴呆伴路易体(DLB)与帕金森病(PD)脑源性α-突触核蛋白种子在RT-QuIC中的播种活性及产物结构。结果显示DLB与PD及对照的播种动力学不同,DLB种子生成蛋白酶K抵抗的纤维状α-突触核蛋白,而PD与对照种子未能转化野生型底物,提示存在不同α-突触核蛋白株。
要点
- DLB与PD脑源性α-突触核蛋白在RT-QuIC中播种动力学不同。
- DLB种子生成蛋白酶K抵抗的纤维状α-突触核蛋白species。
- PD与对照种子未能转化野生型α-突触核蛋白底物。
核心结论
- DLB与PD中α-突触核蛋白播种动力学及产物的结构差异首次提示两组存在不同α-突触核蛋白株。
研究设计与样本
- 研究纳入神经病理学特征明确的DLB、PD和对照病例,取额叶皮质与黑质致密部组织经多步过滤离心富集错误折叠α-突触核蛋白,进行α-突触核蛋白/RT-QuIC分析。
主要发现
- 无论脑区来源,DLB患者RT-QuIC中α-突触核蛋白播种动力学与PD及对照不同。
- DLB种子反应生成蛋白酶K抵抗的纤维状α-突触核蛋白species。
- PD与对照种子未能转化野生型α-突触核蛋白底物。
临床怎么用
- RT-QuIC播种动力学与产物特征有望用于DLB与PD的鉴别诊断。
- 不同α-突触核蛋白株的发现为未来开发株特异性治疗提供方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Currently, the exact reasons why different α-synucleinopathies exhibit variable pathologies and phenotypes are still unknown. A potential explanation may be the existence of distinctive α-synuclein conformers or strains. Here, we intend to analyze the seeding activity of dementia with Lewy bodies (DLB) and Parkinson's disease (PD) brain-derived α-synuclein seeds by real-time quaking-induced conversion (RT-QuIC) and to investigate the structure and morphology of the α-synuclein aggregates generated by RT-QuIC. METHODS: A misfolded α-synuclein-enriched brain fraction from frontal cortex and substantia nigra pars compacta tissue, isolated by several filtration and centrifugation steps, was subjected to α-synuclein/RT-QuIC analysis. Our study included neuropathologically well-characterized cases with DLB, PD, and controls (Ctrl). Biochemical and morphological analyses of RT-QuIC products were conducted by western blot, dot blot analysis, Raman spectroscopy, atomic force microscopy, and transmission electron microscopy. RESULTS: Independently from the brain region, we observed different seeding kinetics of α-synuclein in the RT-QuIC in patients with DLB compared to PD and Ctrl. Biochemical characterization of the RT-QuIC product indicated the generation of a proteinase K-resistant and fibrillary α-synuclein species in DLB-seeded reactions, whereas PD and control seeds failed in the conversion of wild-type α-synuclein substrate. INTERPRETATION: Structural variances of α-synuclein seeding kinetics and products in DLB and PD indicated, for the first time, the existence of different α-synuclein strains in these groups. Therefore, our study contributes to a better understanding of the clinical heterogeneity among α-synucleinopathies, offers an opportunity for a specific diagnosis, and opens new avenues for the future development of strain-specific therapies. Ann Neurol 2019;85:691-703.
引用
- Candelise N, Schmitz M, Llorens F, et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol. 2019. PMID: 30805957. doi:10.1002/ana.25446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。